Compounded Tirzepatide
Dual GIP/GLP-1 Receptor Agonist for Maximum Weight Management
Compounded tirzepatide is the first dual GIP and GLP-1 receptor agonist, prepared by US-licensed 503A pharmacies. By activating two incretin pathways simultaneously, tirzepatide offers enhanced metabolic support. Early-phase clinical data showed dose-dependent weight reduction up to 11.3 kg. All prescriptions require a medical evaluation.
Starting at
$249/mo
Dual
GIP + GLP-1
503A
Licensed Pharmacy
Weekly
Injection
$249
Starting Price/mo
How Compounded Tirzepatide Works
The first dual-action incretin that activates both GIP and GLP-1 receptors for enhanced metabolic support
GLP-1 Receptor Activation
Like semaglutide, activates GLP-1 receptors to reduce appetite, slow gastric emptying, and enhance glucose-dependent insulin secretion.
GIP Receptor Activation
Uniquely activates glucose-dependent insulinotropic polypeptide (GIP) receptors, enhancing insulin sensitivity and potentially improving fat metabolism beyond GLP-1 alone.
Synergistic Metabolic Effect
The dual-receptor mechanism produces complementary metabolic effects that may exceed what either pathway achieves independently, supporting comprehensive weight management.
Compounded Tirzepatide Clinical Context
Tirzepatide is a first-in-class dual GIP/GLP-1 receptor agonist. Early-phase clinical research demonstrated dose-dependent metabolic improvements.
Dual
GIP + GLP-1 Action
11.3 kg
Max Weight Reduction1
2.4%
HbA1c Reduction1
1 Phase 1/2 dose-ranging data. Tirzepatide mechanism review, StatPearls (NBK585056).
ACCP 2025: Real-world compounded GLP-1 ± GIP agonists showed significant positive cardiometabolic outcomes.
Important: Compounded tirzepatide is not FDA-approved. The FDA does not review compounded medications for safety, efficacy, or quality. Individual results vary significantly. Data cited reflects early-phase research and real-world observations, not pivotal randomized controlled trials of compounded formulations.
Why Choose Compounded?
Dual-Receptor Action
First-in-class molecule activating both GIP and GLP-1 receptors for enhanced metabolic support beyond single-pathway agents.
Enhanced Appetite Control
Dual incretin activation may provide stronger appetite suppression and satiety signals than GLP-1 alone.
Weekly Injection
Simple once-weekly subcutaneous injection, same convenient administration as semaglutide.
Metabolic Optimization
GIP receptor activation may improve insulin sensitivity and fat metabolism beyond GLP-1 effects alone.
Provider-Guided
Gradual dose escalation supervised by a licensed provider who adjusts based on your individual response.
Combination Options
May be compounded with B6, B12, L-Carnitine, or Glycine for enhanced support (see below).
Tirzepatide vs Semaglutide
Gradual Dose Escalation
Your provider increases your dose every 4 weeks to optimize results while minimizing side effects
2.5 mg weekly
Starting dose — body begins adapting to dual-receptor activation
5.0 mg weekly
First therapeutic dose — appetite reduction begins
7.5 mg weekly
Increased efficacy — weight loss accelerates
10.0 mg weekly
Strong therapeutic effect — significant results
12.5–15.0 mg weekly
Maximum dose range — peak efficacy (provider-determined)
Expected Results Timeline
Individual results vary significantly. Your physician will customize dosing based on your response, tolerance, and medical history. Compounded tirzepatide is not FDA-approved.
Frequently Asked Questions
Compounded tirzepatide contains the active ingredient tirzepatide prepared by a US-licensed 503A sterile compounding pharmacy. It is the first dual GIP/GLP-1 receptor agonist. Important: Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, efficacy, or manufacturing quality.
Tirzepatide activates both GIP and GLP-1 receptors (dual-action), while semaglutide activates only GLP-1 receptors. This dual mechanism may provide enhanced metabolic effects. However, tirzepatide is newer with less long-term real-world data for compounded formulations. Your provider will help determine which is most appropriate for you.
Your provider may recommend compounding tirzepatide with supportive ingredients: Vitamin B12 (energy support, nausea reduction), Vitamin B6 (protein metabolism, nausea reduction), L-Carnitine (fat oxidation, muscle preservation), or Glycine (antioxidant support, muscle preservation). Your provider will determine the most appropriate formulation.
The most common side effects are gastrointestinal: nausea, diarrhea, vomiting, constipation, and decreased appetite. These are typically mild-to-moderate and often diminish over time. The gradual dose escalation protocol helps minimize these effects. Serious side effects are possible — your provider will discuss all risks.
Tirzepatide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It should not be used during pregnancy or breastfeeding. Patients with a history of pancreatitis or severe gastrointestinal disease may not be candidates. Your provider will conduct a thorough evaluation.
Yes. All prescriptions require a medical evaluation by a licensed healthcare provider in your state. The provider will review your medical history, current medications, and health goals to determine if tirzepatide is medically appropriate. All medical decision-making rests solely with the prescribing provider.
Tirzepatide may be preferred for patients seeking maximum weight management support through its dual GIP/GLP-1 mechanism. It is often chosen when single-pathway GLP-1 therapy has not produced desired results, or when a provider determines the dual mechanism is more appropriate. Semaglutide remains an excellent, more affordable option for many patients.
Ready for Maximum Weight Management Support?
Begin with a medical evaluation by a licensed provider. Compounded tirzepatide starting at $249/month.
Get Started NowFree medical consultation included • Cancel anytime
Enhanced Formulation Options
Your provider may recommend compounding your GLP medication with one or more supportive ingredients based on your individual medical needs and treatment goals.
Vitamin B12 (Methylcobalamin)
Energy & Nausea Support
Why Your Provider May Recommend It
- Helps reduce nausea — one of the most common GLP-1 side effects
- Maintains energy levels during caloric restriction and weight loss
- Supports nervous system health and neurological function
- Helps prevent B12 deficiency, which is common during rapid weight loss
- Supports metabolic efficiency and red blood cell production
Clinical Context: Vitamin B12 deficiency is common in patients undergoing significant dietary changes. Supplementation during GLP-1 therapy may help maintain energy and reduce gastrointestinal side effects.
Vitamin B6 (Pyridoxine)
Metabolism & Nausea Reduction
Why Your Provider May Recommend It
- Supports protein metabolism during weight loss — helps preserve lean mass
- Aids neurotransmitter synthesis (serotonin, dopamine) for mood support
- Well-established anti-nausea properties (used in pregnancy nausea for decades)
- Supports immune function during caloric restriction
- Helps maintain muscle mass during caloric deficit
Clinical Context: Vitamin B6 has a long history of use for nausea reduction and is FDA-approved for nausea of pregnancy. Its role in protein metabolism makes it particularly relevant during weight loss therapy.
L-Carnitine
Fat Oxidation & Muscle Preservation
Why Your Provider May Recommend It
- Facilitates fatty acid transport into mitochondria for energy production
- Enhances fat oxidation during weight loss — helps the body use fat as fuel
- Supports exercise performance and post-workout recovery
- May improve insulin sensitivity and glucose metabolism
- Helps preserve lean muscle mass during caloric deficit
Clinical Context: L-Carnitine plays a critical role in mitochondrial fatty acid oxidation. During weight loss, enhanced fat oxidation may support more favorable body composition outcomes.
Glycine
Antioxidant & Muscle Preservation
Why Your Provider May Recommend It
- Supports glutathione (GSH) production — the body's master antioxidant
- Helps preserve muscle mass during calorie restriction (Caldow et al., 2016)
- May accelerate fat loss during caloric restriction
- Supports sleep quality and natural growth hormone release
- Anti-inflammatory properties that support overall metabolic health
Clinical Context: Glycine is a conditionally essential amino acid that becomes particularly important during caloric restriction. Its role in glutathione synthesis and muscle preservation makes it relevant for patients on GLP-1 therapy.
Medical Necessity Disclaimer
All combination formulations are determined solely by your prescribing provider based on medical necessity, your individual health profile, current medications, and treatment goals. The information above is provided for educational purposes only and does not constitute medical advice.
Not all patients will benefit from or be candidates for combination formulations. Your provider will evaluate whether any additional ingredients are medically appropriate for your specific situation during your consultation.
All compounded medications are prepared by US-licensed 503A pharmacies in accordance with applicable state and federal regulations. Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, efficacy, or manufacturing quality.
All medical decision-making rests solely with the prescribing provider and/or provider group.